Biomatics Capital
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Portal
Select Page

FIERCEBIOTECH NAMES COMPASS THERAPEUTICS A 2018 “FIERCE 15” BIOTECH COMPANY

by bizlift | Oct 2, 2018 | Compass Press Releases, Portfolio News

Compass Therapeutics Completes $132 Million Series A Financing to Advance Next-Generation Antibody-Based Therapeutics into the Clinic

by bizlift | Jul 12, 2018 | Compass Press Releases, Portfolio News

Next Entries »
© Copyright 2025 Biomatics Capital